ArticleEClinicalMedicine2021

Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial.

Alejandro Krolewiecki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.